Since the early 1900’s Johnson & Johnson has proudly advertised its Johnson’s Baby Powder as “Best for the Baby—Best for You.” Although the massive, multinational company continues to stand by this message, it has finally conceded to others who disagree by discontinuing sales of its talc-based baby powder in North America.
The Levin Papantonio law firm is part of a team of law firms heading up litigation to hold hotels and other businesses accountable for their role in facilitating human trafficking.
Although their first request to centralize the litigation was denied by the United States Judicial Panel on Multidistrict Litigation (JPMDL), advocates for survivors continue to push ahead in various jurisdictions across the country fighting for the rights of women and children trafficked on hotel properties and by hotel brands allowing the abuse to continue for years.
There is good progress being made in regards to holding businesses accountable that profit from human trafficking. In December 2019, the first plaintiff to file against a hotel or motel for its role in a trafficking case settled with the Massachusetts motel where she was held captive. The survivor in this case told media the case was more about accountability because employees at the motel saw her in distress and did not help her.
When the markets are down, high yield funds (closed-end “junk” bonds) suffer more than other investment instruments. This is precisely what is happening today.
High yield closed-end funds (CEFs), sometimes referred to as “junk bond funds,” usually trade on stock exchanges, and so supply and demand typically drive their prices. As we experience decreasing confidence and growing instability in the markets, CEF junk bond net asset values (NAVs) are taking a serious hit.
On April 1, 2020, The U.S. Food and Drug Administration (FDA) announced its request that all Zantac brand heartburn drugs, prescription and over-the-counter, be immediately pulled from the market.
The coronavirus outbreak has touched virtually every aspect of our lives, including our court system. On March 18, a New Jersey state court declared it was delaying proceedings in a case against American International Industries, the parent company for talc-product manufacturer Clubman.
In the lawsuit, two hairdressers, Margaret Lashley and Dwayne Johnson, seek justice for their exposure to asbestos in Clubman brand’s cosmetic talc products they used in a barbershop. The plaintiffs claim that this exposure caused their fatal cancer.
Floridian women in the West Palm Beach area, please take note: The Breast Institute in West Palm Beach is unauthorized to perform mammography.
The U.S. Food and Drug Administration (FDA) took corrective action against The Breast Institute, located in West Palm Beach, Florida, after declaring that the mammograms performed by the facility are a “serious risk to human health.”
Bayer opened a Pandora’s box when it acquired Monsanto Co. in 2018. Since acquiring the maker of Roundup weed killer, the multinational pharmaceutical giant has faced lawsuits from nearly 49,000 Roundup users who claim the product causes non-Hodgkin’s lymphoma (NHL).
The small Connecticut-based lab that first sounded the alarm about NDMA contamination in ranitidine (Zantac) is now issuing a similar warning over metformin, a commonly-prescribed, first-line treatment for type-2 diabetes.
A group of women is accusing breast implant manufacturer Allergan of intentionally keeping the public in the dark about the cancer risk their product poses. Six women filed lawsuits against the company for its understated label warnings regarding BIOCELL textured implants, and the plaintiffs explain other ways in which the company’s cloak-and-dagger reporting tactics put the women in harm’s way.
As news coverage of e-cigarette related illnesses has faded into the background, the U.S. House of Representatives took a major step last week by passing the Reversing the Youth Tobacco Epidemic Act, which bans all sales of flavored vape as well as tobacco products, namely menthol cigarettes.
Bayer CEO Werner Baumann's $63 billion gamble on purchasing Monsanto continues to spiral downward. Not only is Bayer facing more than 43,000 glyphosate claims from Roundup users afflicted with cancer, but now, a small army of farmers are lining up to sue the company over dicamba, another Monsanto herbicide that has been destroying food crops.
Twenty-one sex trafficking survivors who filed lawsuits against various hotels where they were victimized will not have their cases consolidated before a single court, the Judicial Panel on Multidistrict Litigation ruled last week.
Despite the fact that all of the cases share the same cause of action – namely, that the hotels failed to train their staff members on how to recognize and report suspected sex trafficking activity – the JPML ruled that the cases were too diverse to be consolidated.
A jury in Johnson & Johnson's home state of New Jersey ordered the health care and cosmetic products giant to pay punitive damages of $750 million in a talc mesothelioma case last week. The verdict comes on top of $37 million in compensatory damages awarded to four plaintiffs who claimed their disease was caused by asbestos-contaminated talc.
Proton pump inhibitors (PPIs) such as Prilosec (omeprazole) and Nexium (esomeprazole) have been linked to numerous serious side effects, ranging from pneumonia, osteoporosis and kidney stones to cardiovascular disease and cancer.
Three juries have determined that glyphosate, the active ingredient in the herbicide Roundup, is a carcinogen. These verdicts are in agreement with the International Agency for Research on Cancer, which concluded that glyphosate is likely to cause cancer, and other scientific studies that have linked glyphosate to the disease. However, recently published research focusing on Roundup's “inert” ingredients suggests that there may be more to it than glyphosate.
Drugmaker Mylan Pharmaceuticals, Inc. has issued a voluntary recall for three lots of the antacid Nizatidine (Axid) after traces of N-Nitrosodimethylamine (NDMA) were discovered in the active ingredient. Although no adverse events have been reported, Mylan is notifying all distributors, retailers, and customers, and has been making arrangements for the return of the affected products.
Last month, Drug Safety News featured a story about Valisure, a small, independent pharmaceutical testing lab in Connecticut that discovered carcinogenic NDMA in Zantac. It wasn't outside contamination – it was a problem with the molecule at the heart of the formulation.
Adding to the list of potential health hazards of “vaping,” a research team at Harvard University's T.H. Chan School of Public Health has discovered a biocontaminant in JUUL vape oil that can lead to serious, long-term respiratory damage.
Six Roundup cancer cases are scheduled to go to trial right after the New Year, even as Bayer is attempting to negotiate a global settlement in Berlin. Among those plaintiffs are two children who suffer from non-Hodgkin's lymphoma (NHL), allegedly due to exposure to glyphosate, the active ingredient in the herbicide.
800.277.1193
Phone